1. Home
  2. AYTU vs NBY Comparison

AYTU vs NBY Comparison

Compare AYTU & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • NBY
  • Stock Information
  • Founded
  • AYTU N/A
  • NBY 2000
  • Country
  • AYTU United States
  • NBY United States
  • Employees
  • AYTU N/A
  • NBY N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • AYTU Health Care
  • NBY
  • Exchange
  • AYTU Nasdaq
  • NBY Nasdaq
  • Market Cap
  • AYTU 18.8M
  • NBY 15.7M
  • IPO Year
  • AYTU N/A
  • NBY 2007
  • Fundamental
  • Price
  • AYTU $2.37
  • NBY $1.17
  • Analyst Decision
  • AYTU Strong Buy
  • NBY Strong Buy
  • Analyst Count
  • AYTU 3
  • NBY 1
  • Target Price
  • AYTU $9.17
  • NBY $0.85
  • AVG Volume (30 Days)
  • AYTU 393.1K
  • NBY 1.0M
  • Earning Date
  • AYTU 11-12-2025
  • NBY 11-06-2025
  • Dividend Yield
  • AYTU N/A
  • NBY N/A
  • EPS Growth
  • AYTU N/A
  • NBY N/A
  • EPS
  • AYTU N/A
  • NBY 0.41
  • Revenue
  • AYTU $66,382,000.00
  • NBY $9,781,000.00
  • Revenue This Year
  • AYTU N/A
  • NBY $23.91
  • Revenue Next Year
  • AYTU $19.03
  • NBY $32.05
  • P/E Ratio
  • AYTU N/A
  • NBY $3.29
  • Revenue Growth
  • AYTU 1.84
  • NBY 113.47
  • 52 Week Low
  • AYTU $0.95
  • NBY $0.46
  • 52 Week High
  • AYTU $2.82
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 57.62
  • NBY 43.47
  • Support Level
  • AYTU $1.65
  • NBY $1.16
  • Resistance Level
  • AYTU $1.98
  • NBY $1.64
  • Average True Range (ATR)
  • AYTU 0.16
  • NBY 0.19
  • MACD
  • AYTU 0.03
  • NBY -0.15
  • Stochastic Oscillator
  • AYTU 70.30
  • NBY 6.99

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: